How much do you agree with the following statements? *

	Strongly disagree	Disagree	Slightly disagree	Neither	Slightly agree	Agree	Strongly agree
The activity presented balanced, evidence-based content free of commercial bias.	The activity presented balanced, evidence-based content free of commercial bias. - Strongly disagree	The activity presented balanced, evidence-based content free of commercial bias. - Disagree	The activity presented balanced, evidence-based content free of commercial bias. - Slightly disagree	The activity presented balanced, evidence-based content free of commercial bias. - Neither	The activity presented balanced, evidence-based content free of commercial bias. - Slightly agree	The activity presented balanced, evidence-based content free of commercial bias. - Agree	The activity presented balanced, evidence-based content free of commercial bias. - Strongly agree
The presenter(s) used an effective teaching strategy.	The presenter(s) used an effective teaching strategy. - Strongly disagree	The presenter(s) used an effective teaching strategy. - Disagree	The presenter(s) used an effective teaching strategy. - Slightly disagree	The presenter(s) used an effective teaching strategy. - Neither	The presenter(s) used an effective teaching strategy. - Slightly agree	The presenter(s) used an effective teaching strategy. - Agree	The presenter(s) used an effective teaching strategy. - Strongly agree
The presentation slides / digital materials / resources and handouts were high quality.	The presentation slides / digital materials / resources and handouts were high quality. - Strongly disagree	The presentation slides / digital materials / resources and handouts were high quality. - Disagree	The presentation slides / digital materials / resources and handouts were high quality. - Slightly disagree	The presentation slides / digital materials / resources and handouts were high quality. - Neither	The presentation slides / digital materials / resources and handouts were high quality. - Slightly agree	The presentation slides / digital materials / resources and handouts were high quality. - Agree	The presentation slides / digital materials / resources and handouts were high quality. - Strongly agree
The content was relevant to / useful for my professional practice.	The content was relevant to / useful for my professional practice. - Strongly disagree	The content was relevant to / useful for my professional practice. - Disagree	The content was relevant to / useful for my professional practice. - Slightly disagree	The content was relevant to / useful for my professional practice. - Neither	The content was relevant to / useful for my professional practice. - Slightly agree	The content was relevant to / useful for my professional practice. - Agree	The content was relevant to / useful for my professional practice. - Strongly agree
The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care.	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Strongly disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Slightly disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Neither	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Slightly agree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Agree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Strongly agree
The overall quality of the educational activity was excellent.	The overall quality of the educational activity was excellent. - Strongly disagree	The overall quality of the educational activity was excellent. - Disagree	The overall quality of the educational activity was excellent. - Slightly disagree	The overall quality of the educational activity was excellent. - Neither	The overall quality of the educational activity was excellent. - Slightly agree	The overall quality of the educational activity was excellent. - Agree	The overall quality of the educational activity was excellent. - Strongly agree

The activity successfully achieved its learning objectives by enhancing my ability to: *

	Strongly disagree	Disagree	Slightly disagree	Neither	Slightly agree	Agree	Strongly agree
Identify the differences in the newest version of the Pharmacy Operations and Drug Control.	Identify the differences in the newest version of the Pharmacy Operations and Drug Control. - Strongly disagree	Identify the differences in the newest version of the Pharmacy Operations and Drug Control. - Disagree	Identify the differences in the newest version of the Pharmacy Operations and Drug Control. - Slightly disagree	Identify the differences in the newest version of the Pharmacy Operations and Drug Control. - Neither	Identify the differences in the newest version of the Pharmacy Operations and Drug Control. - Slightly agree	Identify the differences in the newest version of the Pharmacy Operations and Drug Control. - Agree	Identify the differences in the newest version of the Pharmacy Operations and Drug Control. - Strongly agree
Evaluate the processes for standing up Emergency Medical and Tactical Combat Casualty Care at a unit.	Evaluate the processes for standing up Emergency Medical and Tactical Combat Casualty Care at a unit. - Strongly disagree	Evaluate the processes for standing up Emergency Medical and Tactical Combat Casualty Care at a unit. - Disagree	Evaluate the processes for standing up Emergency Medical and Tactical Combat Casualty Care at a unit. - Slightly disagree	Evaluate the processes for standing up Emergency Medical and Tactical Combat Casualty Care at a unit. - Neither	Evaluate the processes for standing up Emergency Medical and Tactical Combat Casualty Care at a unit. - Slightly agree	Evaluate the processes for standing up Emergency Medical and Tactical Combat Casualty Care at a unit. - Agree	Evaluate the processes for standing up Emergency Medical and Tactical Combat Casualty Care at a unit. - Strongly agree
Identify strategies for communicating with diverse populations.	Identify strategies for communicating with diverse populations. - Strongly disagree	Identify strategies for communicating with diverse populations. - Disagree	Identify strategies for communicating with diverse populations. - Slightly disagree	Identify strategies for communicating with diverse populations. - Neither	Identify strategies for communicating with diverse populations. - Slightly agree	Identify strategies for communicating with diverse populations. - Agree	Identify strategies for communicating with diverse populations. - Strongly agree
Apply active listening techniques in simulated interactions.	Apply active listening techniques in simulated interactions. - Strongly disagree	Apply active listening techniques in simulated interactions. - Disagree	Apply active listening techniques in simulated interactions. - Slightly disagree	Apply active listening techniques in simulated interactions. - Neither	Apply active listening techniques in simulated interactions. - Slightly agree	Apply active listening techniques in simulated interactions. - Agree	Apply active listening techniques in simulated interactions. - Strongly agree
Summarize scope and impact Formulary Management has on the TRICARE pharmacy benefit.	Summarize scope and impact Formulary Management has on the TRICARE pharmacy benefit. - Strongly disagree	Summarize scope and impact Formulary Management has on the TRICARE pharmacy benefit. - Disagree	Summarize scope and impact Formulary Management has on the TRICARE pharmacy benefit. - Slightly disagree	Summarize scope and impact Formulary Management has on the TRICARE pharmacy benefit. - Neither	Summarize scope and impact Formulary Management has on the TRICARE pharmacy benefit. - Slightly agree	Summarize scope and impact Formulary Management has on the TRICARE pharmacy benefit. - Agree	Summarize scope and impact Formulary Management has on the TRICARE pharmacy benefit. - Strongly agree
Describe the mission and responsibilities of the DoD Pharmacy & Therapeutics (P&T) Committee and the Formulary Management Branch.	Describe the mission and responsibilities of the DoD Pharmacy & Therapeutics (P&T) Committee and the Formulary Management Branch. - Strongly disagree	Describe the mission and responsibilities of the DoD Pharmacy & Therapeutics (P&T) Committee and the Formulary Management Branch. - Disagree	Describe the mission and responsibilities of the DoD Pharmacy & Therapeutics (P&T) Committee and the Formulary Management Branch. - Slightly disagree	Describe the mission and responsibilities of the DoD Pharmacy & Therapeutics (P&T) Committee and the Formulary Management Branch. - Neither	Describe the mission and responsibilities of the DoD Pharmacy & Therapeutics (P&T) Committee and the Formulary Management Branch. - Slightly agree	Describe the mission and responsibilities of the DoD Pharmacy & Therapeutics (P&T) Committee and the Formulary Management Branch. - Agree	Describe the mission and responsibilities of the DoD Pharmacy & Therapeutics (P&T) Committee and the Formulary Management Branch. - Strongly agree
Describe the organization and mission of the DHA Formulary Branch.	Describe the organization and mission of the DHA Formulary Branch. - Strongly disagree	Describe the organization and mission of the DHA Formulary Branch. - Disagree	Describe the organization and mission of the DHA Formulary Branch. - Slightly disagree	Describe the organization and mission of the DHA Formulary Branch. - Neither	Describe the organization and mission of the DHA Formulary Branch. - Slightly agree	Describe the organization and mission of the DHA Formulary Branch. - Agree	Describe the organization and mission of the DHA Formulary Branch. - Strongly agree
Explain the steps involved in the DHA Formulary Branch Review Process.	Explain the steps involved in the DHA Formulary Branch Review Process. - Strongly disagree	Explain the steps involved in the DHA Formulary Branch Review Process. - Disagree	Explain the steps involved in the DHA Formulary Branch Review Process. - Slightly disagree	Explain the steps involved in the DHA Formulary Branch Review Process. - Neither	Explain the steps involved in the DHA Formulary Branch Review Process. - Slightly agree	Explain the steps involved in the DHA Formulary Branch Review Process. - Agree	Explain the steps involved in the DHA Formulary Branch Review Process. - Strongly agree
Evaluate a travel itinerary using TRAVAX and develop medication and vaccine recommendations for a specific destination by augmenting Centers for Disease Control and Prevention (CDC) advisories with USCG and COCOM recommendations.	Evaluate a travel itinerary using TRAVAX and develop medication and vaccine recommendations for a specific destination by augmenting Centers for Disease Control and Prevention (CDC) advisories with USCG and COCOM recommendations. - Strongly disagree	Evaluate a travel itinerary using TRAVAX and develop medication and vaccine recommendations for a specific destination by augmenting Centers for Disease Control and Prevention (CDC) advisories with USCG and COCOM recommendations. - Disagree	Evaluate a travel itinerary using TRAVAX and develop medication and vaccine recommendations for a specific destination by augmenting Centers for Disease Control and Prevention (CDC) advisories with USCG and COCOM recommendations. - Slightly disagree	Evaluate a travel itinerary using TRAVAX and develop medication and vaccine recommendations for a specific destination by augmenting Centers for Disease Control and Prevention (CDC) advisories with USCG and COCOM recommendations. - Neither	Evaluate a travel itinerary using TRAVAX and develop medication and vaccine recommendations for a specific destination by augmenting Centers for Disease Control and Prevention (CDC) advisories with USCG and COCOM recommendations. - Slightly agree	Evaluate a travel itinerary using TRAVAX and develop medication and vaccine recommendations for a specific destination by augmenting Centers for Disease Control and Prevention (CDC) advisories with USCG and COCOM recommendations. - Agree	Evaluate a travel itinerary using TRAVAX and develop medication and vaccine recommendations for a specific destination by augmenting Centers for Disease Control and Prevention (CDC) advisories with USCG and COCOM recommendations. - Strongly agree
Compare weight loss medications and navigate the Tricare prior authorization process.	Compare weight loss medications and navigate the Tricare prior authorization process. - Strongly disagree	Compare weight loss medications and navigate the Tricare prior authorization process. - Disagree	Compare weight loss medications and navigate the Tricare prior authorization process. - Slightly disagree	Compare weight loss medications and navigate the Tricare prior authorization process. - Neither	Compare weight loss medications and navigate the Tricare prior authorization process. - Slightly agree	Compare weight loss medications and navigate the Tricare prior authorization process. - Agree	Compare weight loss medications and navigate the Tricare prior authorization process. - Strongly agree
Identify opportunities to fill voids and expand pharmaceutical practice in USCG.	Identify opportunities to fill voids and expand pharmaceutical practice in USCG. - Strongly disagree	Identify opportunities to fill voids and expand pharmaceutical practice in USCG. - Disagree	Identify opportunities to fill voids and expand pharmaceutical practice in USCG. - Slightly disagree	Identify opportunities to fill voids and expand pharmaceutical practice in USCG. - Neither	Identify opportunities to fill voids and expand pharmaceutical practice in USCG. - Slightly agree	Identify opportunities to fill voids and expand pharmaceutical practice in USCG. - Agree	Identify opportunities to fill voids and expand pharmaceutical practice in USCG. - Strongly agree
Differentiate between basic USCG basic pharmaceutical services and expanded pharmaceutical services, scope, and reach.	Differentiate between basic USCG basic pharmaceutical services and expanded pharmaceutical services, scope, and reach. - Strongly disagree	Differentiate between basic USCG basic pharmaceutical services and expanded pharmaceutical services, scope, and reach. - Disagree	Differentiate between basic USCG basic pharmaceutical services and expanded pharmaceutical services, scope, and reach. - Slightly disagree	Differentiate between basic USCG basic pharmaceutical services and expanded pharmaceutical services, scope, and reach. - Neither	Differentiate between basic USCG basic pharmaceutical services and expanded pharmaceutical services, scope, and reach. - Slightly agree	Differentiate between basic USCG basic pharmaceutical services and expanded pharmaceutical services, scope, and reach. - Agree	Differentiate between basic USCG basic pharmaceutical services and expanded pharmaceutical services, scope, and reach. - Strongly agree
Describe the Unified Pharmacy Leaders Intent.	Describe the Unified Pharmacy Leaders Intent. - Strongly disagree	Describe the Unified Pharmacy Leaders Intent. - Disagree	Describe the Unified Pharmacy Leaders Intent. - Slightly disagree	Describe the Unified Pharmacy Leaders Intent. - Neither	Describe the Unified Pharmacy Leaders Intent. - Slightly agree	Describe the Unified Pharmacy Leaders Intent. - Agree	Describe the Unified Pharmacy Leaders Intent. - Strongly agree
Relate the goals of Force Design 2028 to the Unified Pharmacy Leaders Intent.	Relate the goals of Force Design 2028 to the Unified Pharmacy Leaders Intent. - Strongly disagree	Relate the goals of Force Design 2028 to the Unified Pharmacy Leaders Intent. - Disagree	Relate the goals of Force Design 2028 to the Unified Pharmacy Leaders Intent. - Slightly disagree	Relate the goals of Force Design 2028 to the Unified Pharmacy Leaders Intent. - Neither	Relate the goals of Force Design 2028 to the Unified Pharmacy Leaders Intent. - Slightly agree	Relate the goals of Force Design 2028 to the Unified Pharmacy Leaders Intent. - Agree	Relate the goals of Force Design 2028 to the Unified Pharmacy Leaders Intent. - Strongly agree
Describe the role of pharmacists in facilitating a ready force.	Describe the role of pharmacists in facilitating a ready force. - Strongly disagree	Describe the role of pharmacists in facilitating a ready force. - Disagree	Describe the role of pharmacists in facilitating a ready force. - Slightly disagree	Describe the role of pharmacists in facilitating a ready force. - Neither	Describe the role of pharmacists in facilitating a ready force. - Slightly agree	Describe the role of pharmacists in facilitating a ready force. - Agree	Describe the role of pharmacists in facilitating a ready force. - Strongly agree
Identify case examples where USCG pharmacists improved force readiness.	Identify case examples where USCG pharmacists improved force readiness. - Strongly disagree	Identify case examples where USCG pharmacists improved force readiness. - Disagree	Identify case examples where USCG pharmacists improved force readiness. - Slightly disagree	Identify case examples where USCG pharmacists improved force readiness. - Neither	Identify case examples where USCG pharmacists improved force readiness. - Slightly agree	Identify case examples where USCG pharmacists improved force readiness. - Agree	Identify case examples where USCG pharmacists improved force readiness. - Strongly agree
Identify the mission specialties of each Deployable Specialized Forces type.	Identify the mission specialties of each Deployable Specialized Forces type. - Strongly disagree	Identify the mission specialties of each Deployable Specialized Forces type. - Disagree	Identify the mission specialties of each Deployable Specialized Forces type. - Slightly disagree	Identify the mission specialties of each Deployable Specialized Forces type. - Neither	Identify the mission specialties of each Deployable Specialized Forces type. - Slightly agree	Identify the mission specialties of each Deployable Specialized Forces type. - Agree	Identify the mission specialties of each Deployable Specialized Forces type. - Strongly agree
Explain the chemical, biological, radiological, nuclear or explosive (CBRNE) requirements and opportunities for a unit.	Explain the chemical, biological, radiological, nuclear or explosive (CBRNE) requirements and opportunities for a unit. - Strongly disagree	Explain the chemical, biological, radiological, nuclear or explosive (CBRNE) requirements and opportunities for a unit. - Disagree	Explain the chemical, biological, radiological, nuclear or explosive (CBRNE) requirements and opportunities for a unit. - Slightly disagree	Explain the chemical, biological, radiological, nuclear or explosive (CBRNE) requirements and opportunities for a unit. - Neither	Explain the chemical, biological, radiological, nuclear or explosive (CBRNE) requirements and opportunities for a unit. - Slightly agree	Explain the chemical, biological, radiological, nuclear or explosive (CBRNE) requirements and opportunities for a unit. - Agree	Explain the chemical, biological, radiological, nuclear or explosive (CBRNE) requirements and opportunities for a unit. - Strongly agree

What do you anticipate changing or how will you apply what you learned in your professional practice? *

How will you apply what you learned when working with providers of other disciplines or members of your interprofessional healthcare team? *

What barriers, if any, do you see to implementing these changes? *

Please provide feedback on your experience navigating this website and completing the CE process. *

Based on your educational needs, what topics would you like to see addressed in future educational activities? *

Please discuss any additional concerns or comments about this program and indicate whether the program met your expectations. *

attestation checkbox *

I completed this educational activity independently and in its entirety.

Leave this field blank